MetLife Q4 2025 Earnings Exceed Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4d ago
0mins
Should l Buy MET?
Source: seekingalpha
- Earnings Growth: MetLife reported an adjusted EPS of $2.58 for Q4 2025, surpassing the $2.34 analyst estimate and up 24% from $2.08 in Q4 2024, indicating a significant improvement in profitability.
- Revenue Analysis: Total revenue reached $23.8 billion, falling short of the $31.6 billion consensus but increasing 27% from $18.7 billion year-over-year, reflecting the company's efforts in diversifying income streams, particularly in Group Benefits and Retirement Solutions.
- Investment Income Improvement: Adjusted net investment income rose to $5.58 billion in Q3 2025, up from $5.30 billion in Q4 2024, demonstrating the company's effectiveness in investment management and market adaptability.
- Segment Performance: Group Benefits grew by 12% year-over-year, Retirement and Income Solutions by 18%, while Europe, the Middle East, and Africa surged by 64%, showcasing MetLife's strong performance and successful strategic positioning in global markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MET?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MET
Wall Street analysts forecast MET stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MET is 95.25 USD with a low forecast of 84.00 USD and a high forecast of 108.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 76.380
Low
84.00
Averages
95.25
High
108.00
Current: 76.380
Low
84.00
Averages
95.25
High
108.00
About MET
MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
MetLife Q4 2025 Earnings Exceed Expectations
- Earnings Growth: MetLife reported an adjusted EPS of $2.58 for Q4 2025, surpassing the $2.34 analyst estimate and up 24% from $2.08 in Q4 2024, indicating a significant improvement in profitability.
- Revenue Analysis: Total revenue reached $23.8 billion, falling short of the $31.6 billion consensus but increasing 27% from $18.7 billion year-over-year, reflecting the company's efforts in diversifying income streams, particularly in Group Benefits and Retirement Solutions.
- Investment Income Improvement: Adjusted net investment income rose to $5.58 billion in Q3 2025, up from $5.30 billion in Q4 2024, demonstrating the company's effectiveness in investment management and market adaptability.
- Segment Performance: Group Benefits grew by 12% year-over-year, Retirement and Income Solutions by 18%, while Europe, the Middle East, and Africa surged by 64%, showcasing MetLife's strong performance and successful strategic positioning in global markets.
See More
MetLife Reports Decline in Q4 Profit
- Profit Decline: MetLife's Q4 net profit fell to $778 million, or $1.17 per share, down from $1.239 billion and $1.78 per share last year, indicating significant earnings pressure on the company.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $1.709 billion, or $2.58 per share, showing some resilience in profitability despite the overall profit decline.
- Revenue Growth: The company's revenue rose 27.6% year-over-year to $23.814 billion from $18.666 billion last year, indicating strong business expansion and market demand.
- Market Impact: Despite revenue growth, the profit decline may negatively affect investor confidence, particularly as the company faces intense competition and market volatility.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
MetLife to Announce Q4 Earnings on February 4th
- Earnings Announcement: MetLife (MET) is set to release its Q4 2023 earnings on February 4th after market close, with consensus EPS estimates at $2.34, reflecting a 12% year-over-year increase, indicating sustained profitability.
- Strong Revenue Expectations: The anticipated revenue for Q4 is $31.63 billion, representing a remarkable 69.4% year-over-year growth, which underscores MetLife's robust market performance and rising customer demand in the insurance and financial services sectors.
- Performance Uncertainty: Over the past two years, MetLife has only beaten EPS and revenue estimates 38% of the time, suggesting a level of uncertainty in the company's performance forecasts that could impact investor confidence.
- Revision Trends: In the last three months, EPS estimates have seen 4 upward revisions and 6 downward revisions, while revenue estimates have experienced 3 upward revisions with no downward adjustments, indicating mixed market sentiment regarding MetLife's future performance.
See More
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
MetLife Q4 2025 Earnings Exceed Expectations
- Earnings Growth: MetLife reported an adjusted EPS of $2.58 for Q4 2025, surpassing the $2.34 analyst estimate and up 24% from $2.08 in Q4 2024, indicating a significant improvement in profitability.
- Revenue Analysis: Total revenue reached $23.8 billion, falling short of the $31.6 billion consensus but increasing 27% from $18.7 billion year-over-year, reflecting the company's efforts in diversifying income streams, particularly in Group Benefits and Retirement Solutions.
- Investment Income Improvement: Adjusted net investment income rose to $5.58 billion in Q3 2025, up from $5.30 billion in Q4 2024, demonstrating the company's effectiveness in investment management and market adaptability.
- Segment Performance: Group Benefits grew by 12% year-over-year, Retirement and Income Solutions by 18%, while Europe, the Middle East, and Africa surged by 64%, showcasing MetLife's strong performance and successful strategic positioning in global markets.
See More
MetLife Reports Decline in Q4 Profit
- Profit Decline: MetLife's Q4 net profit fell to $778 million, or $1.17 per share, down from $1.239 billion and $1.78 per share last year, indicating significant earnings pressure on the company.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $1.709 billion, or $2.58 per share, showing some resilience in profitability despite the overall profit decline.
- Revenue Growth: The company's revenue rose 27.6% year-over-year to $23.814 billion from $18.666 billion last year, indicating strong business expansion and market demand.
- Market Impact: Despite revenue growth, the profit decline may negatively affect investor confidence, particularly as the company faces intense competition and market volatility.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
MetLife to Announce Q4 Earnings on February 4th
- Earnings Announcement: MetLife (MET) is set to release its Q4 2023 earnings on February 4th after market close, with consensus EPS estimates at $2.34, reflecting a 12% year-over-year increase, indicating sustained profitability.
- Strong Revenue Expectations: The anticipated revenue for Q4 is $31.63 billion, representing a remarkable 69.4% year-over-year growth, which underscores MetLife's robust market performance and rising customer demand in the insurance and financial services sectors.
- Performance Uncertainty: Over the past two years, MetLife has only beaten EPS and revenue estimates 38% of the time, suggesting a level of uncertainty in the company's performance forecasts that could impact investor confidence.
- Revision Trends: In the last three months, EPS estimates have seen 4 upward revisions and 6 downward revisions, while revenue estimates have experienced 3 upward revisions with no downward adjustments, indicating mixed market sentiment regarding MetLife's future performance.
See More
